Prognostic factors and a new scoring system for survival of patients irradiated for bone metastases

BACKGROUND: Personalized therapy for bone metastases should consider the patients’ remaining lifespan. Estimation of survival can be facilitated with scoring tools. A new tool was developed, specifically designed to estimate 12-month survival. METHODS: In 445 patients irradiated for bone metastases,...

Descripción completa

Detalles Bibliográficos
Autores principales: Rades, Dirk, Haus, Rapha, Schild, Steven E., Janssen, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883567/
https://www.ncbi.nlm.nih.gov/pubmed/31779595
http://dx.doi.org/10.1186/s12885-019-6385-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883567/
https://www.ncbi.nlm.nih.gov/pubmed/31779595
http://dx.doi.org/10.1186/s12885-019-6385-7

Ejemplares similares